Securities and Exchange Commission. Asterisks denote omissions. Product License and Supply AgreementLicense and Supply Agreement • December 22nd, 2006 • Collagenex Pharmaceuticals Inc • Pharmaceutical preparations • Pennsylvania
WHEREAS, CollaGenex filed and on 27 May, 2006 the U.S. Food and Drug Administration approved, New Drug Application 50/805 covering the marketing and sale of a 40mg controlled release doxycycline monohydrate capsule conforming to the specifications described in such application (such product being referred to as the “Product”), and
